arrow
M

Ming-Lung Yu

kaohsiung medical university
H指数:71
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Clinical Utility of Adding Laminin Gamma 2 Monomer to the PAGE‐B Score for Hepatocellular Carcinoma Surveillance in Chronic Hepatitis B

在慢性乙型肝炎患者中,将层粘连蛋白γ2单体加入PAGE-B评分以用于肝细胞癌监测的临床应用价值

2026-10-080
PRE
Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction-Associated Steatotic Liver Disease

代谢功能障碍相关脂肪性肝病中用于疾病严重程度预测的心血管代谢生物标志物

2026-09-130
OAAI
Association Between ADH1B rs1229984 Genetic Polymorphism and Hepatic Steatosis Assessed by CT Attenuation: A Mediation Analysis of Central Obesity in MASLD

ADH1B rs1229984基因多态性与CT衰减值评估的肝脂肪变性之间的关联:中央性肥胖在MASLD中的中介分析

2026-09-070
PRE
Hidden asymptomatic breakthrough infection in a proof-of-concept longitudinal study on SARS-CoV-2 vaccine recipients

在SARS-CoV-2疫苗接种者概念验证纵向研究中发现的隐性无症状突破性感染

2026-07-220
OAAI
Asia-Pacific perspectives on the steatotic liver disease (SLD) reclassification: balancing terminology, diagnostic criteria, and implementation

亚太地区对脂肪性肝病(SLD)重新分类的观点:平衡术语、诊断标准与实施

2026-06-180
OAAI
Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy

慢性丙型肝炎患者经治愈性抗病毒治疗后,心血管代谢危险因素和脂肪性肝病对肝脏相关结局的影响

2026-04-220
OAAI
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty Survey

妊娠期丙型肝炎治疗:医师观点——一项跨国多专科调查

2026-04-060
PRE
High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C

高正常值范围及异常丙氨酸转氨酶水平与慢性丙型肝炎治疗后肝癌风险增加相关

2026-04-012
OAAI
GWAS Study Identifies 3-SNP Risk Variants of PNPLA3/SAMM50 Linked to HCC Development in Individuals with Non-viral Liver Diseases

全基因组关联研究识别出PNPLA3/SAMM50的3个单核苷酸多态性风险变异,这些变异与非病毒性肝病患者中肝细胞癌的发生相关。

2025-11-110
OAAI
The association between dietary quercetin intake and risk of depressive symptoms: the TCLSIH cohort study

膳食槲皮素摄入量与抑郁症状风险之间的关联:TCLSIH队列研究

2025-11-100
PRE